Please enter the email address you used to register, then we will send you a link to choose a new password
Innovate (NYSE:VATE) reported quarterly losses of $(1.67) per share. This is a 267 percent decrease over earnings of $1.00 per ...
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with norma...
Innovate (NYSE:VATE) reported quarterly losses of $(1.18) per share. This is a 31.11 percent decrease over losses of $(0.90) pe...